Cargando…
IDF21-0110 The role of source hypoglycemic therapy and associated diseases in patients with type 2 diabetes mellitus and COVID-19
Autores principales: | Markova, T.N., Ponomareva, A.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Scientific Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164789/ http://dx.doi.org/10.1016/j.diabres.2022.109316 |
Ejemplares similares
-
IDF21-0109 Coagulation Disorders in Type 2 Diabetes Mellitus Patients with COVID-19
por: Syukur, C., et al.
Publicado: (2022) -
IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic
por: Almutairi, M., et al.
Publicado: (2022) -
IDF21-0367 Descriptive study of infection by SARS-COV-2 in adults with Diabetes Mellitus
por: Russo, M.P., et al.
Publicado: (2022) -
IDF21-0539 Can the asymptomatic COVID-19 trigger the development of diabetes mellitus?
por: Jashi, L., et al.
Publicado: (2022) -
EHMTI-0110. Epidemiology of primary headaches in the population of Baku
por: Aliyev, R, et al.
Publicado: (2014)